Skip to Main Content

NISH (NITAG Support Hub) 11: Measles Containing Vaccine (MCV) Vial Presentation Switch LibGuide: Home

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of the Measles Containing Vaccine (MCV) switch to support NITAGs

Introduction

What is  measles

Measles is a highly contagious disease caused by a virus. It spreads easily when an infected person breathes, coughs or sneezes. It can cause severe disease, complications, and even death WHO, (2024).

World Health Organization. (2020). Measles and rubella strategic framework: 2021-2030. In Measles and rubella strategic framework: 2021-2030.

 https://iris.who.int/handle/10665/339801.

World Health Organization/Igor Sergienko (202?). Measles and Rubella Laboratory Network.

https://www.who.int/europe/initiatives/measles-and-rubella-laboratory-network

What is Measles Containing Vaccine (MCV) switch

AI overview

MCV switch

 "MCV switch" likely refers to a change in the vial size or brand of Measles Cough Vaccine Measles-Cough-Vaccine (MCV): This likely refers to a vaccine containing measles, mumps, and rubella (MMR) antigens, which are often combined in a single vaccine ...used in routine immunization programs, potentially to improve efficiency or reduce wastage.

 

MCV 5-dose Vial Switch Assessment Tool

More and more countries are making the decision to switch from 10-dose to 5-dose Measels Containing Vaccine (MCV) vials as an opportunity to reduce missed opportunities for vaccination in routine immunization

See: https://www.technet-21.org/en/resources/tool/mcv-5-dose-vial-switch-assessment-tool

Measles and Rubella Map

(Measles and Rubella Partnership, 2024).